Upgrade to SI Premium - Free Trial

Corvus Pharma (CRVS)

14.39 -0.26 (1.77%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/29/26)

Latest Headlines

Corvus Pharmaceuticals publishes soquelitinib Phase 1 T cell data in Blood August 27, 2026 7:30 AM - StreetInsider Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1b T Cell Lymphoma Trial August 27, 2026 7:30 AM - Globe NewsWire Form SCHEDULE 13G Corvus Pharmaceuticals, Filed by: STATE STREET CORP August 7, 2026 9:17 AM - SEC Filing Corvus Pharmaceuticals, Inc. (CRVS) Misses Q2 EPS by 4c August 6, 2026 5:55 PM - StreetInsider Form 10-Q Corvus Pharmaceuticals, For: Jun 30 August 6, 2026 4:06 PM - SEC Filing Form 8-K Corvus Pharmaceuticals, For: Aug 06 August 6, 2026 4:03 PM - SEC Filing Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2026 Financial Results August 6, 2026 4:01 PM - Globe NewsWire Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2026 Financial Results on August 6, 2026 July 30, 2026 4:01 PM - Globe NewsWire Ladenburg Thalmann Assumes Corvus Pharmaceuticals (CRVS) at Buy July 29, 2026 12:26 PM - StreetInsider Form SCHEDULE 13G/A Corvus Pharmaceuticals, Filed by: BlackRock, Inc. July 27, 2026 4:28 PM - SEC Filing Form 8-K Corvus Pharmaceuticals, For: Jul 21 July 22, 2026 4:02 PM - SEC Filing Form 4 Corvus Pharmaceuticals, For: Jun 11 Filed by: Moore David Scott June 15, 2026 5:12 PM - SEC Filing Form 4 Corvus Pharmaceuticals, For: Jun 11 Filed by: CLARK IAN T June 15, 2026 5:10 PM - SEC Filing Form 4 Corvus Pharmaceuticals, For: Jun 11 Filed by: Grais Linda June 15, 2026 5:08 PM - SEC Filing Form 4 Corvus Pharmaceuticals, For: Jun 11 Filed by: Thompson Peter A. June 15, 2026 5:07 PM - SEC Filing Form 4 Corvus Pharmaceuticals, For: Jun 11 Filed by: van den Broek Richard June 15, 2026 5:04 PM - SEC Filing Form 8-K Corvus Pharmaceuticals, For: Jun 11 June 12, 2026 4:01 PM - SEC Filing Corvus Pharmaceuticals invests $5 million in Angel Pharmaceuticals June 9, 2026 7:30 AM - StreetInsider Corvus Pharmaceuticals Announces Additional Investment in Angel Pharmaceuticals to Advance the Development of Soquelitinib in China June 9, 2026 7:30 AM - Globe NewsWire Full Article List